(Q44592749)
Statements
1 reference
Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice (English)
1 reference
Oral Synthetic Phospholipid (DMPC) Raises High-Density Lipoprotein Cholesterol Levels, Improves High-Density Lipoprotein Function, and Markedly Reduces Atherosclerosis in Apolipoprotein E–Null Mice (English)
Mohamad Navab
1 reference
Susan Hama
1 reference
Greg Hough
1 reference
Alan M. Fogelman
22 September 2003
1 reference
1 reference
Identifiers
1 reference